Transcriptomic profiling of intermediate cell carcinoma of the liver

Area of Science:

• Hepatobiliary cancers
• Cancer genomics
• Molecular oncology

Background:

• Intermediate cell carcinoma (Int-CA) is a rare primary liver cancer with mixed features of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
• The molecular underpinnings of Int-CA remain largely uncharacterized despite its distinct pathology.

Purpose of the Study:

• To elucidate the molecular landscape of Int-CA.
• To identify distinct molecular features differentiating Int-CA from HCC and ICC.
• To explore the functional role of identified molecular alterations in Int-CA pathogenesis.

Main Methods:

• Comprehensive transcriptomic and genomic profiling of Int-CA tumors.
• Comparative analysis with HCC and ICC molecular data.
• Functional experiments to investigate the role of METTL16 in tumor progression.

Main Results:

• Int-CA exhibits a unique transcriptomic profile distinct from HCC and ICC.
• Frequent intron retention events and prominent Notch signaling activation are signature features of Int-CA.
• METTL16 suppression, linked to DNA copy number alterations, was identified and experimentally shown to promote invasive tumor characteristics via Notch signaling activation.

Conclusions:

• Int-CA is characterized by METTL16 suppression and frequent intron retention events.
• These molecular alterations likely contribute to the aggressive phenotype observed in Int-CA.
• This study provides a molecular framework for understanding Int-CA and suggests potential therapeutic targets.